Administrative
Core
Emergency
Preparedness
Activity
Diagnostics Development
Core
Computational
Biology Core
Law,
Policy, and Ethics Core
|
Emergency
Preparedness Activity
Collaborating Institution: Texas A&M Health Science Center
School of Rural Public Health (TAM HSC), Houston, TX
WRCE Associate Director for Emergency Preparedness: Scott Lillibridge,
MD
WRCE Assistant Director for Emergency Preparedness: Dennis Perrotta,
PhD, CIC – TAM HSC, Houston, TX
Description: The Emergency Preparedness and Response component
of WRCE is headed by the Associate Director, Scott Lillibridge,
MD. This year WRCE preparedness activities will revolve around
issues delineated within the DHHS Pandemic and All-Hazards Preparedness
Act (PAHPA). Specifically, this will involve activities related
to pandemic influenza preparedness, surge capacity, and early detection
and reporting of public health threats. In addition, we plan to
use pandemic influenza preparedness as a model threat scenario
for our various WRCE members for improving our scientific capacities
(integrating new technical core platforms) to respond to biodefense
and emerging infectious disease emergencies.
Specific activities
include:
Participation in a collaborative conference with WRCE
partners, focusing on the major biodefense and emerging
infectious
disease threats to our population.
Ongoing crisis leadership training in public health
preparedness in conjunction with state health departments
of WRCE members.
The application of new WRCE technologies to foster
enhanced surveillance for biodefense and emerging
infectious disease.
Continued refinement of the WRCE emergency communications
structure among key leadership personnel, and partnership
activity designed
to further discussions to integrate the WRCE into
state and regional emergency preparedness plans.
Continued linkage of the WRCE with the World
Health Organization’s
(WHO) emerging infectious disease, preparedness,
and health and security agenda through the attendance
and participation in pertinent
WHO sponsored meetings related to pandemic influenza,
biodefense, or emerging infectious disease.
|